NMAD - LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Scanr.ai
NMAD
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Manufacturing
|
Pharmaceutical Products
|
XNAS
4.43
-0.08
-1.80%
Jul 28, 3:58 PM EDT
Enlarge chart
Fullscreen chart
O 4.38H 4.68L 4.2C 4.43Vol 366.08K
Jul 28, 2026
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Lixte Biotechnology Holdings, Inc. uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets.The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development.
